EUVIMEDEUVIMED entdecken
Open Access

Targeting the ENO1 metabolic checkpoint via microenvironment-responsive nanotherapeutics promotes postinfarction cardiac repair

Ruoshui Li iD, Gaoyang Li iD, Jie Li iD, Zekun Lou, Xuerou Jin, Jun Yan, Hongping Chen, Fang Zhang, Xiaoran Deng iD, Tongda Xu iD

Science Advances · 2026

DOI: 10.1126/sciadv.aeg3270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Ruoshui Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Phosphopyruvate Hydratase, DNA-Binding Proteins, Cellular Microenvironment. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Government of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial infarction (MI) triggers persistent inflammatory dysregulation, wherein macrophages undergo glycolytic reprogramming and adopt an inflammatory phenotype that impairs cardiac repair. However, the specific metabolic drivers underlying post-MI macrophage dysfunction remain unclear. Here, we identify enolase 1 (ENO1)—a glycolytic enzyme up-regulated in post-MI macrophages—as a critical regulator of macrophage metabolic fate and inflammatory function. To intervene, we engineered an acid-responsive nanocarrier (PECS) that externalizes phosphatidylserine within the acidic infarct microenvironment, facilitating selective macrophage uptake. Intracellular delivery of siENO1 suppressed glycolytic flux, thereby curbing lactate accumulation and relieving its metabolic inhibition of KLF4, which initiated anti-inflammatory reprogramming. In vivo, PECS-loaded siENO1 (siENO1@PECS) treatment attenuated infarct size, fibrosis, and cardiomyocyte apoptosis while improving ventricular function. Collectively, these findings identify ENO1 as a critical metabolic checkpoint in post-MI macrophage regulation and demonstrate a bioresponsive nanocarrier strategy for precise gene modulation to enhance cardiac repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionPhosphopyruvate HydrataseDNA-Binding ProteinsCellular MicroenvironmentTumor Suppressor ProteinsNanoparticlesAnimalsMacrophagesMiceKruppel-Like Factor 4Myocytes, CardiacApoptosisHumansKruppel-Like Transcription FactorsMetabolic ReprogrammingGlycolysis

Substanzen

Phosphopyruvate HydrataseDNA-Binding ProteinsKruppel-Like Factor 4Tumor Suppressor ProteinsKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Institute of Cardiovascular Disease Research, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Province Key Laboratory in Anesthesiology and Brain Science, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Department of Cardiology, Huashan Hospital, Fudan University, Shanghai, China.
  • School of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, Jiangsu, China.

ORCID-Profile: Ruoshui Li, Gaoyang Li, Jie Li, Xiaoran Deng, Tongda Xu

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Government of Jiangsu Province
  • Xuzhou Medical University
  • Xuzhou Municipal Health Commission Medical Science and Technology Innovation Project
  • Xuzhou Medical Science and Technology Innovation Program
  • Paired Assistance Scientific Research Project by The Affiliated Hospital of Xuzhou Medical University
  • Advanced Program of The Affiliated Hospital of Xuzhou Medical University

Zitieren

APA

Li, R., Li, G., Li, J., Lou, Z., Jin, X., Yan, J., Chen, H., Zhang, F., Deng, X., & Xu, T. (2026). Targeting the ENO1 metabolic checkpoint via microenvironment-responsive nanotherapeutics promotes postinfarction cardiac repair. Science Advances. https://doi.org/10.1126/sciadv.aeg3270

Vancouver

Li R, Li G, Li J, Lou Z, Jin X, Yan J, et al. Targeting the ENO1 metabolic checkpoint via microenvironment-responsive nanotherapeutics promotes postinfarction cardiac repair. Science Advances. 2026. doi:10.1126/sciadv.aeg3270

BibTeX
@article{Li2026,
  author = {Li, Ruoshui and Li, Gaoyang and Li, Jie and Lou, Zekun and Jin, Xuerou and Yan, Jun and Chen, Hongping and Zhang, Fang and Deng, Xiaoran and Xu, Tongda},
  title = {Targeting the ENO1 metabolic checkpoint via microenvironment-responsive nanotherapeutics promotes postinfarction cardiac repair},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aeg3270}
}
Kostenlos starten →